Related Experiment Video
Updated: Dec 30, 2025

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
Published on: October 3, 2016
Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation
Thomas V Inglesby1, Marc Lipsitch2
1Center for Health Security, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA tinglesby@jhu.edu.
Abstract:
We propose here changes to the U.S. government policy on potential pandemic pathogen (PPP) oversight and implementation, emphasizing transparency of the review process and the content of the review, publication of the review in advance, responsible publication of enhanced PPP research, high-level signoff on approvals of enhanced PPP experiments, and the need for a significant effort to establish a common international approach to enhanced PPP work. We advocate that the U.S. government recommend, and non-U.S. government funders and journals adopt, a set of best practices that would extend important considerations of biosafety and biosecurity to all work on enhanced potential pandemic pathogens regardless of funding source.
Related Concept Videos
Steps in Outbreak Investigation
Principles of Disease Surveillance
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

